6533b81ffe1ef96bd1277c12

RESEARCH PRODUCT

Bladder augmentation and urinary diversion in patients with neurogenic bladder: Non-surgical considerations

Joachim W. ThüroffRaimund SteinAnnette Schröder

subject

medicine.medical_specialtyColonbusiness.industryPatient Selectionmedicine.medical_treatmentUrologyUrinary diversionUrologyVitamin B 12 DeficiencyUrinary DiversionPrognosislcsh:Diseases of the genitourinary system. Urologylcsh:RC870-923Bile Acids and SaltsPostoperative ComplicationsBladder augmentationIleumPediatrics Perinatology and Child HealthmedicineHumansIn patientUreterUrinary Bladder NeurogenicAcidosisbusiness

description

Segments from almost all parts of the bowel have been used for urinary diversion. As a result, the available absorptive surface area of the bowel is reduced, and the incorporation of bowel segments into the urinary tract may have metabolic consequences. This is an area somewhat neglected in the literature. Metabolic complications are rare, but sub-clinical metabolic disturbances are quite common. Several studies have demonstrated that some of the absorbent and secreting properties of the bowel tissue are preserved after incorporation into the urinary tract. Hyperchloraemic metabolic acidosis can occur if ileal and/or colon segments are used, as well as malabsorption of vitamin B(12) and bile acid after the use of ileal segments. These metabolic effects are not as severe as may be suspected and can be prevented by prophylactic substitution. Secondary malignancies can develop as a long-term consequence of bladder augmentation. Using colonic segments, tumours are most likely to occur at the ureteral implantation site. To prevent metabolic complications, careful patient selection and meticulous and lifelong follow up, as well as prophylactic treatment, are mandatory. Endoscopy for early detection has been recommended, starting 10 years postoperatively for patients who underwent surgery for a benign condition.

https://doi.org/10.1016/j.jpurol.2011.03.015